Announcing a new article publication for Cardiovascular Innovations and Applications journal. Coronary no-reflow phenomenon (NRP), a common adverse complication in patients with ST-segment elevation ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Reflow Medical, Inc. announced that it has received FDA commercial clearance for its coraCatheters™, a complete line of state-of-the-art microcatheters ...
Weight-loss (GLP-1 mimicking) drugs may help prevent further tissue damage following a heart attack, significantly reducing the risk of further life-threatening complications that affect up to half of ...
Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results